| |
||
|
Catalogue Number |
Product | Order number / Unit |
| |
||
| 2051 | 3-O-Trityl-6-O-desmethyl-phenethyl-orvinol |
2051.0002: 2 mg per vial
Please inquire for customized filling and bulk quantities. 
|
|
Precursor for [11C]Phenethyl-orvinol
|
||
| Molar Mass: 701.89 | ||
| C48H47NO4 | ||
| [1187551-69-4] | ||
| Colourless to yellowish solid packaged in dark glass crimp cap vials. | ||
| Purity: > 95 % | ||
|
Certificates:
CoA; 1H and 13C NMR spectra |
||
|
Chemical Name: CA index name: 6,14-Ethenomorphinan-7-methanol, -4,5-epoxy-6-hydroxy-α,17-dimethyl-,α-(2-phenylethyl)-3-(triphenylmethoxy)-, (5α, 7α) |
||
|
Synonymes: TDPEO |
||
|
Literature: Marton J. et al. Synthesis and evaluation of a full-agonist orvinol for PET-imaging of opioid receptors: [11C]PEO J. Med. Chem. 2009, 52, 5586-5589. |
||
| Schoultz B.W. et al. Synthesis and evaluation of three structurally related 18F-labeled orvinols of different intrinsic activities: [18F]fluoroethyl-diprenorphine ([18F]FDPN), [18F]fluoroethyl-buprenorphine ([18F]FBPN and [18F]fluoroethyl-phenethyl-orvinol ([18F]FPEO. J. Med. Chem. 2014, 57, 5464-5469. | ||
| date of product catalogue issue: 10 May 2017 | ||